Diflorasone Topical (Psorcon, Florone, Maxiflor)
Jump to navigation
Jump to search
Indications
- short-term treatment of inflammation & pruritus secondary to severe steroid-responsive dermatoses
- cutaneous T-cell lymphoma
- discoid lupus
- psoriasis
- lichen simplex chronicus
- granuloma annulare[3]
Dosage
Very high potency (0.05%), (15, 30, 60 g).
Adverse effects
- uncommon (< 1%)
- burning, itching, irritation, dryness, folliculitis, hypertrichosis, acne, hypopigmentation, perioral dermatitis, allergic contact dermatitis, skin maceration, secondary infection, skin atrophy, striae, miliaria
- drug adverse effects of glucocorticoids
- drug adverse effects of topical glucocorticoids
- drug adverse effects of immunosuppressive agents
More general terms
References
- ↑ The Pharmacological Basis of Therapeutics, 9th ed. Gilman et al, eds. Permagon Press/McGraw Hill, 1996
- ↑ Kaiser Permanente Northern California Regional Drug Formulary, 1998
- ↑ 3.0 3.1 Deprecated Reference
- ↑ Medical Knowledge Self Assessment Program (MKSAP) 17, American College of Physicians, Philadelphia 2015